Clinical Trials
2 trialsNCT05940896 2023-11-27
RC48-ADC Combined With Radiotherapy in the Treatment of Locally Advanced Solid Tumors With HER2 Expression
RemeGen Co., Ltd.
Phase 1 Recruiting
NCT05649163 2022-12-16
Real-world Study of HER2-overexpressed Advanced Solid Tumors After Progression of First-line Standard Therapy
Peking University
Unknown